Atlas FDA

CINtec PLUS Cytology

FDA premarket approval P190024/S014 · decided 2025-07-31

Approval details

PMA number
P190024
Supplement
S014
Supplement type
Real-Time Process
Supplement reason
Change Design/Components/Specifications/Material
Trade name
CINtec PLUS Cytology
Generic name
Immunocytochemistry assay, p16/Ki-67
Applicant
Ventana Medical Systems, Inc.
Date received
2025-05-06
Decision date
2025-07-31
Days to decision
86 days
Decision code
APPR
Product code
QKF
Advisory committee
Pathology
Expedited review
No
Location
Tucson, AZ
Statement
Approval for changes to the concentration of a device component.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Roche Digital Pathology Dx (K242783)Ventana Medical Systems, Inc.2024-12-17
VENTANA Kappa and Lambda Dual ISH mRNA Probe Cocktail (08507023001) (DEN240025)Ventana Medical Systems, Inc.2024-12-05
Roche Digital Pathology Dx (VENTANA DP 200) (K232879)Ventana Medical Systems, Inc.2024-06-14
CINtec Histology (K212176)Ventana Medical Systems, Inc.2021-12-10
VENTANA CD30 (Ber-H2) RxDx Assay (K172471)Ventana Medical Systems, Inc.2018-05-08
CINtec Histology (50 tests), CINtec Histology (250 tests) (DEN160019)Ventana Medical Systems, Inc.2017-03-04
Virtuoso System for IHC PR (1E2) using iScan HT (K142965)Ventana Medical Systems, Inc.2015-07-16
VIRTUOSO SYSTEM FOR IHC ER (SP1) WITH BENCHMARK ULTRA STAINER (K140465)Ventana Medical Systems, Inc.2014-03-20